|
1
|
Manganaro AM, Hammond HL, Dalton MJ and
Williams TP: Oral melanoma: Case reports and review of the
literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
80:670–676. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rapini RP: Oral melanoma: Diagnosis and
treatment. Semin Cutan Med Surg. 16:320–322. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gazit D and Daniels TE: Oral melanocytic
lesions: Differences in expression of HMB-45 and S-100 antigens in
round and spindle cells of malignant and benign lesions. J Oral
Pathol Med. 23:60–64. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hirano T: Immunohistochemical study of
malignant melanoma. Acta Pathol Jpn. 36:733–743. 1986.PubMed/NCBI
|
|
5
|
Tanaka N, Amagasa T, Iwaki H, Shioda S,
Takeda M, Ohashi K and Reck SF: Oral malignant melanoma in Japan.
Oral Surg Oral Med Oral Pathol. 78:81–90. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tanaka N, Mimura M, Ichinose S and Odajima
T: Malignant melanoma in the oral region: Ultrastructural and
immunohistochemical studies. Med Electron Microsc. 34:198–205.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Prasad ML, Jungbluth AA, Iversen K, Huvos
AG and Busam KJ: Expression of melanocytic differentiation markers
in malignant melanomas of the oral and sinonasal mucosa. Am J Surg
Pathol. 25:782–787. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kilpatrick SE, White WL and Browne JD:
Desmoplastic malignant melanoma of the oral mucosa. An
underrecognized diagnostic pitfall. Cancer. 78:383–389. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blessing K, Sanders DS and Grant JJ:
Comparison of immunohistochemical staining of the novel antibody
melan-A with S100 protein and HMB-45 in malignant melanoma and
melanoma variants. Histopathology. 32:139–146. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jungbluth AA, Busam KJ, Gerald WL,
Stockert E, Coplan KA, Iversen K, MacGregor DP, Old LJ and Chen YT:
A103: An anti-Melan-a monoclonal antibody for the detection of
malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol.
22:595–602. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barrett AW, Bennett JH and Speight PM: A
clinicopathological and immunohistochemical analysis of primary
oral mucosal melanoma. Eur J Cancer B Oral Oncol. 31B:100–105.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moore BW: A soluble protein characteristic
of the nervous system. Biochem Biophys Res Commun. 19:739–744.
1965. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakajima T, Watanabe S, Sato Y, Kameya T,
Shimosato Y and Ishihara K: Immunohistochemical demonstration of
S100 protein in malignant melanoma and pigmented nevus and its
diagnostic application. Cancer. 50:912–918. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nobuyuki T, Teruo A, Hiroshi I, Shigetoshi
S, Masamune T, Kenichi O and Steven F: Oral malignant melanoma in
Japan. Oral Surg Oral Med Oral Pathol. 78:81–90. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gown AM, Vogel AM, Hoak D, Gough F and
McNutt MA: Monoclonal antibodies specific for melanocytic tumors
distinguish subpopulations of melanocytes. Am J Pathol.
123:195–203. 1986.PubMed/NCBI
|
|
16
|
Rapini RP, Golitz LE, Greer RO Jr,
Krekorian EA and Poulson T: Primary malignant melanoma of the oral,
cavity. A review of 177 cases. Cancer. 55:1543–1551. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sensi M, Traversari C, Radrizzani M, Salvi
S, Maccalli C, Mortarini R, Rivoltini L, Farina C, Nicolini G,
Wolfel T, et al: Cytotoxic T-lymphocyte clones from different
patients display limited T-cell-receptor variable-region gene usage
in HLA-A2-restricted recognition of the melanoma antigen
Melan-A/MART-1. Proc Natl Acad Sci USA. 92:5674–5678. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Salvi S, Segalla F, Rao S, Arienti F,
Sartori M, Bratina G, Caronni E, Anichini A, Clemente C, Parmiani
G, et al: Overexpression of the T-cell receptor beta-chain variable
region TCRBV14 in HLA-A2-matched primary human melanomas. Cancer
Res. 55:3374–3379. 1995.PubMed/NCBI
|
|
19
|
Ishida H, Nagai T, Sato S, Honda M, Uotani
T, Samejima K, Hanaoka T, Akahori T, Takai Y and Seki H:
Concomitant sentinel lymph node biopsy leading to abbreviated
systematic lymphadenectomy in a patient with primary malignant
melanoma of the vagina. Springerplus. 4:1022015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tanaka N, Mimura M, Kimijima Y and Amagasa
T: Clinical investigation of amelanotic malignant melanoma in the
oral region. J Oral Maxillofac Surg. 62:933–937. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ariel IM: Amelanotic melanomas: An
analysis of 77 patients. Curr Surg. 38:151–155. 1981.PubMed/NCBI
|
|
22
|
Fujita S, Takahashi H, Tsuda N and Okabe
H: Immunohistochemical localization of S-100 protein and its
subunits in melanotic lesion in the oral mucosa and skin. J Oral
Pathol Med. 20:429–432. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Naoki O Kawada: The stage of melanogenesis
in amelanotic melanoma. Melanoma in the Clinic - Diagnosis,
Management and Complications of Malignancy. Murph M: (InTech).
277–283. 2011.
|
|
24
|
Naoki O, Masuki Y, Shigeru K and Akira K:
Amelanotic vulvar melanoma with intratumor histological
heterogeneity. J Dermatol. 37:537–5412010.
|
